Patents Assigned to Pharmacia Groningen BV
  • Patent number: 6849669
    Abstract: The invention relates to macromolecular hydrophilic photocrosslinkers having polymeric backbones of substituted ethylene groups carrying photoactive groups. The photocrosslinkers are capable of producing, when being exposed to light of determined wavelengths above 305 nm, radicals which are retained on the macromolecular photocrosslinkers and reacting so as to accomplish a crosslinked network structure. The invention further relates to the preparation of photocrosslinkers, their use in different aqueous systems and their utility in production of medical devices including ophthalmic lenses.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: February 1, 2005
    Assignee: Pharmacia Groningen BV
    Inventors: Kenneth A. Hodd, Keith Alfred Dillingham, Jacqueline deGroot, Hendrik Haitjema
  • Patent number: 6846875
    Abstract: The present invention relates to new hydrogels with improved mechanical properties and methods of their preparation. The hydrogels are formed from hydrophilic polymers having function hydroxyl groups and have low elasticity modulus typically less than about 10 kPa, a tensile strength above 1 MPa, an elongation above 50% which makes suitable as medical implants, in particular intraocular lenses. The hydrogels are prepared by a crosslinking method with a comparatively low concentration of hydrophilic polymer of a sufficiently high molecular weight dissolved in a good solvent.
    Type: Grant
    Filed: April 10, 2001
    Date of Patent: January 25, 2005
    Assignee: Pharmacia Groningen BV
    Inventors: Albert Johan Pennings, Coenraad Jan Spaans, Jacqueline Hermina deGroot
  • Patent number: 6767934
    Abstract: Macromolecular photocrosslinkers have polymeric backbones of substituted siloxane groups carrying photoactive groups. When exposed to light of wavelength above 305 nm, the photocrosslinkers are adapted to generate radicals which are retained on the macromolecular photocrosslinker and react to form a crosslinked network structure. The photocrosslinkers may be used in the production of medical devices, including ophthalmic lenses.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: July 27, 2004
    Assignee: Pharmacia Groningen BV
    Inventors: Kenneth A. Hodd, Keith Alfred Dillingham
  • Patent number: 6747090
    Abstract: The invention related to a hydrogel forming aqueous composition of water soluble polymers having a sufficiently high coherency that it substantially not is dispersed when being injected into an aqueous environment of a body site such as the capsular bag of the eye to undergo a photoinitiated crosslinking reaction. The water soluble polymers either can be a water-soluble polymer bearing free acrylic, or other vinylic groups capable of facile free radical reaction with a polymeric water-soluble photoinitiator also present in the composition, or a water-soluble polymer bearing both free acrylic, or other vinylic groups capable of facile free radical reaction and photoinitiator, wherein both polymers are capable of being crosslinked when irradiated with light of wavelengths greater than about 305 nm to form the hydrogel.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: June 8, 2004
    Assignee: Pharmacia Groningen BV
    Inventors: Jacqueline Hermina De Groot, Kenneth Albert Hodd, Hendrik Jan Haitjema
  • Patent number: 6737496
    Abstract: The present invention relates to photocurable siloxane polymers having functional acryl groups, useful in the preparation of intraocular lenses (IOLs). The polymers are siloxane copolymers, wherein the siloxane can be selected from the group consisting of diphenyl siloxane, phenylalkyl siloxane, dialkyl siloxane, and trifluoroalkyl alkyl siloxane. The invention also relates to methods for producing the said siloxane polymers, as well as to producing accommodating lenses in vivo, which means that the lens is formed in the capsular bag of the eye.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: May 18, 2004
    Assignee: Pharmacia Groningen BV
    Inventors: Kenneth A. Hodd, Sverker Norrby
  • Patent number: 6705729
    Abstract: An intraocular correction lens and a method of designing such a lens. According to the invention the lens is capable of reducing aberrations of an eye after its implantation and it is adapted to be placed between the cornea and the capsular bag of the eye.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: March 16, 2004
    Assignee: Pharmacia Groningen BV
    Inventors: Patricia Ann Piers, Sverker Norrby
  • Patent number: 6613343
    Abstract: The present invention relates to compositions comprising polysiloxanes suitable for the preparation of accommodating intraocular lenses, having a specific gravity of greater than about 1.0, a refractive index suitable for restoring the refractive power of the natural crystalline lens and a viscosity suitable for injection through a standard cannula. The present invention includes intraocular lenses made from said polysiloxane compositions having a Young's modulus less than about 10 kPa.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: September 2, 2003
    Assignee: Pharmacia Groningen BV
    Inventors: Keith Alfred Dillingham, Hendrik Deuring, Jöns Gunnar Hilborn, László Garamszegi, Kenneth Albert Hodd, Hendrik Jan Haitjema
  • Patent number: 6609793
    Abstract: The present invention discloses methods of obtaining ophthalmic lens capable of reducing the aberrations of the eye comprising the steps of characterizing at least one corneal surface as a mathematical model, calculating the resulting aberrations of said corneal surface(s) by employing said mathematical model, selecting the optical power of the intraocular lens. From this information, an ophthalmic lens is modeled so a wavefront arriving from an optical system comprising said lens and corneal model obtains reduced aberrations in the eye. Also disclosed are ophthalmic lenses as obtained by the methods which are capable reducing aberrations of the eye.
    Type: Grant
    Filed: May 23, 2001
    Date of Patent: August 26, 2003
    Assignee: Pharmacia Groningen BV
    Inventors: Sverker Norrby, Pablo Artal, Patricia Ann Piers, Marrie Van Der Mooren
  • Patent number: 6598606
    Abstract: The vision of an eye having an impaired lens is stored with an artificial lens implant. The method involves replacing the lens by a polymerizable material injected into the emptied lens capsule and thereby providing a new lens implant with a predetermined refractive value, while admitting the possibility of controlling and adjusting the refractive value of the eye during the surgical process.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: July 29, 2003
    Assignee: Pharmacia Groningen BV
    Inventors: Thomas Henricus Marie Terwee, Hendrick Albert Weeber, Patricia Ann Piers
  • Patent number: 6589550
    Abstract: A method for producing an intraocular lens, comprising the steps of injecting a high-refractive index, low viscosity composition of crosslinkable units into an enclosure and initiating polymerization under pressure to create a synthetic polymer lens. The method is especially suitable for producing an intraocular lens directly in the capsular bag of the eye from an injected aqueous solution of macromolecular particles, which can undergo a crosslinking reaction to a solid lens when exposed to light.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: July 8, 2003
    Assignee: Pharmacia Groningen BV
    Inventors: Kenneth A. Hodd, Keith Alfred Dillingham, Jacqueline de Groot
  • Patent number: 6533814
    Abstract: Intraocular lens comprising a central optical body and haptics attached to or formed integrally with said optical body wherein the haptics are attached to the optical body via connecting members separating the haptic plane from the optical plane by a distance b which is at least half the thickness of the optical body.
    Type: Grant
    Filed: January 16, 2001
    Date of Patent: March 18, 2003
    Assignee: Pharmacia Groningen, BV
    Inventor: Peter Jansen